Donadio Stefano, Monciardini Paolo, Sosio Margherita
KtedoGen, Via Fantoli, Milano, Italy.
Methods Enzymol. 2009;458:3-28. doi: 10.1016/S0076-6879(09)04801-0.
The need for novel antibiotics to fight multidrug-resistant pathogens calls for a return to natural product screening, but novel approaches must be implemented to increase the chances of discovering novel compounds. This chapter illustrates strategic considerations and the required ingredients for screening programs: microbial diversity, samples for screening, targets and assays, assay development and implementation, hit identification and follow-up. When appropriate, we highlight the impact that chemical diversity consisting of mixtures of different compounds, amid a large background of known antibiotics, has on the screening process. Examples of detailed procedures are described for strain isolation and preservation, sample preparation, primary and secondary assays, and extract fractionation. While these limited examples are not sufficient to organize a complete screening program, they provide a basis for understanding the details of microbial product screening in the anti-infective field.
对抗多重耐药病原体需要新型抗生素,这就要求回归到天然产物筛选,但必须采用新方法以增加发现新化合物的机会。本章阐述了筛选计划的战略考量和所需要素:微生物多样性、筛选样品、靶点与检测方法、检测方法的开发与实施、活性化合物鉴定及后续研究。在适当的时候,我们强调了在大量已知抗生素背景下,由不同化合物混合物组成的化学多样性对筛选过程的影响。文中描述了菌株分离与保存、样品制备、一级和二级检测以及提取物分级分离的详细操作流程示例。虽然这些有限的示例不足以组织一个完整的筛选计划,但它们为理解抗感染领域微生物产物筛选的细节提供了基础。